Zumutor Biologics raised $7.3 million in a Pre-Series B round.
- Amount
- $7.3M
- Stage
- Pre-Series B
- Announced
- 15 June 2026
- Leads
- Accel, Bharat Innovation Fund, Premji Invest, Ashish Kacholia, Raj Dandu Family Office
- Use of funds
- Complete ongoing US FDA Phase 1 trial of ZM008, start Phase 1B expansion cohorts and global Phase 2 studies.
- Checked
- Amount and date matched across 2 press sources